Ligand validation:2X94

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2X94_EPE_A_701	12%	32%	0.28	0.808	0.83	1.94	1	6	9	0	100%	0.7
2X91_EPE_A_1618	77%	33%	0.11	0.951	0.87	1.87	1	4	0	0	100%	1
2X90_EPE_A_1616	66%	33%	0.127	0.934	0.83	1.93	1	6	5	0	100%	1
2X93_EPE_A_1241	57%	32%	0.142	0.916	0.83	1.94	1	6	0	0	100%	1
2XHM_EPE_A_1617	54%	31%	0.202	0.969	0.89	1.98	1	5	0	0	100%	1
2X92_EPE_A_701	53%	33%	0.153	0.914	0.83	1.93	1	6	2	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	45%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	18%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	29%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	45%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.